No Data
No Data
Express News | The concept of Weight Loss Drugs is experiencing a sharp rise, with Jinkai Biotechnology reaching the daily limit of a 20% increase.
A-share afternoon review: Chinext Price Index fell by 0.68%, over 4,100 stocks declined! Electrical Utilities and The Pet Economy Concept rose against the market.
As of the noon close, the Shanghai Composite Index fell 0.1% to 3,292.98 points, the Shenzhen Component Index fell 0.66%, and the Chinext Price Index fell 0.68%.
A-shares fluctuate丨Q1 performance is impressive! Jinkai Biotechnology and Asymchem Laboratories hit the limit up, driving the CRO sector to strengthen collectively.
On April 24, Gelonghui reported that strong performance stimulated Jin Kai Bio to hit the 20% daily limit, Asymchem Laboratories to hit the 10% daily limit, further driving a collective rise of A-share CRO concept stocks. Haofan Biological rose over 6%, Chengda Pharmaceutical rose over 4%, PHARMARON, Wanbang Pharmaceutical, Wuhan Hiteck Biological Pharma, Xinjiang Bai Hua Cun Pharma Tech, and Nuotai Biological rose over 3%. Jin Kai Bio disclosed in its earnings report last night that it achieved revenue of 0.176 billion yuan in the first quarter of 2025, a year-on-year increase of 41.83%, and net income attributable to the shareholders of the listed company of 47.417 million yuan, a year-on-year increase of 183.24%. Asymchem Laboratories announced last night...
Kingchem: Summary of the 2024 Annual Report
Kingchem: 2024 Annual Report
Kingchem: 2025 First Quarter Report